1 Marijuana Stock That Could Knock Canopy (TSX:WEED) Off its Perch

Tilray stock could become well positioned to take over the top spot in the legal cannabis industry due to its merger with Aphria and dethrone Canopy Growth.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Canopy Growth (TSX:WEED)(NYSE:CGC) has long been considered the industry leader for cannabis producers in Canada. Lately, the consumer sentiment for the company has been quite low, and that reflects in its falling share prices.

Canopy Growth stock peaked at $66.21 per share on February 10, 2021. Since its February peak, the stock has been on a downward trajectory that does not seem like it will slow down anytime soon. The stock is trading for $30.25 per share at writing, translating to a 54% decline in just four months.

The stock might no longer be capable of holding onto its leadership position for long. Tilray (TSX:TLRY)(NASDAQ:TLRY) has recently made moves that could position it well to knock Canopy Growth off its high perch to become the new industry leader in the cannabis space.

A crucial market

The U.S. market presents a key opportunity for Canadian cannabis companies. Most Canadian cannabis producers are itching at the opportunity to pounce if and when the U.S. government decides to legalize marijuana at a federal level. While the legalization movement has picked up momentum throughout the U.S., there is no timeline for when marijuana will no longer be considered an illegal substance, according to federal law in the U.S.

A recent bill filed in the U.S. Congress could prove to be the critical turning point that Canadian cannabis companies have been waiting for so that they can finally enter the lucrative market. The proposed bill aims to protect financial institutions and other businesses in non-cannabis legal states for them to work with cannabis companies.

Tilray’s bid for the top spot

Tilray shares began trading on the TSX in May this year after its merger with Aphria was approved. The two combined market capital for Aphria and Tilray might be lower than the massive $11.40 billion market cap that Canopy Growth boasts. However, that does not mean it will remain the case for long.

Aphria is the surviving entity after the merger, and it trades under the Tilray name after the merger. The Aphria CEO and chairman Irwin D. Simon will now head the merged companies. The merger has combined the strength of Tilray’s medical cannabis operations in Europe and Australia with Aphria’s recreational marijuana business in Canada.

The combined companies have several other revenue streams, including Manitoba Harvest and SweetWater. SweetWater is Aphria’s leading cannabis lifestyle-branded craft brewer, and Manitoba is a Tilray company that sells CBD products and hemp granola.

Aphria focuses on acquiring brands in the consumer product space to help it grow beyond cannabis. Tilray is an innovator and pioneer in cannabis research, production, cultivation, and distribution.

Foolish takeaway

Canopy Growth, Tilray, and other Canadian cannabis producers will have a tough battle to come out on top in the U.S. market. The combined power of Aphria and Tilray could provide the company an edge over its Canadian and even American counterparts in the race to become the top cannabis company in North America.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »